Branded

ORLANDO, Fla. — Sanofi Pasteur on Wednesday launched an awareness campaign to inform Florida residents ages 65 years and older about the importance of influenza protection and the key role vaccination plays in helping to improve the body's immune response against the virus.

Adults 65 years of age and older typically are the hardest hit by influenza. This new program, called Influenza Immunization for You, urges older adults to talk to their healthcare provider about vaccine options. Florida Hospital Medical Group is spearheading the initiative in the region.

BERLIN — Walgreens was awarded the Retail Advertising Campaign of the Year at the Oracle World Retail Awards here at the German Historical Museum during the annual World Retail Congress held Tuesday.

The Retail Advertising Campaign of the Year celebrates outstanding advertising campaigns undertaken by a retailer to build the brand. Walgreens was selected over the competition and was awarded the prize due to its “Arm Yourself for the Ones You Love” campaign by Arc Worldwide.

INDIANAPOLIS — A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

Lilly released results of the 939-patient phase-3 "PARAMOUNT" study, which found that maintenance therapy with the injected drug Alimta (pemetrexed), added to the chemotherapy drug cisplatin, reduced the risk of disease progression in patients ages 70 years and older with advanced nonsquamous no-small cell lung cancer, or NSCLC.

HORSHAM, Pa. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis in children.

J&J subsidiary Janssen Biotech said Friday that the FDA approved Remicade (infliximab) for moderately to severely active ulcerative colitis in children who have not responded adequately to conventional therapies.

PRINCETON, N.J., and LA JOLLA, Calif. — Two drug makers have entered a collaboration for novel biologics programs in diabetes and heart failure.

Under the partnership, Bristol-Myers Squibb will receive exclusive worldwide rights to research, develop and commercialize biologics, based on research by Ambrx of fibroblast growth factor 21 (FGF-21) protein and relaxin hormone, which potentially can treat Type 2 diabetes and heart failure, respectively.

SAN DIEGO — Drug maker Orexigen Therapeutics said it had identified a "clear and feasible path" for the approval of its drug for treating obesity by working with the Food and Drug Administration.

CHICAGO — A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

LOS ANGELES — Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

The researchers, at UCLA's Larry L. Hillblom Islet Research Center, examined incidents reported in the Food and Drug Administration's adverse event database between 2004 and 2009 among patients using Byetta (exenatide), made by Eli Lilly and Amylin Pharmaceuticals, and Merck's Januvia (sitagliptin).